influenza
virus
caus
varieti
ill
human
common
infect
season
influenza
usual
mild
selflimit
febril
syndrom
sever
infant
elderli
immunodefici
person
progress
sever
viral
pneumon
complic
bacteri
superinfect
lead
pneumonia
sepsi
season
influenza
also
occasion
result
neurolog
complic
rare
virus
spread
wild
bird
domest
poultri
infect
human
avian
influenza
rang
sever
mild
conjunct
rapidli
lethal
diseas
seen
person
infect
viru
first
emerg
hong
kong
develop
effect
therapi
wide
rang
diseas
essenti
laboratori
anim
model
replic
major
featur
ill
human
review
describ
model
current
use
elucid
influenza
pathogenesi
evalu
new
therapeut
agent
influenza
virus
infect
human
respons
gamut
ill
rang
inappar
infect
pneumonia
sever
acut
respiratori
syndrom
typic
infect
one
associ
season
influenza
mild
selflimit
febril
syndrom
respiratori
virus
influenza
virus
caus
sever
infect
infant
elderli
immunodefici
person
individu
whose
immun
system
compromis
fulli
develop
influenzaassoci
diseas
often
lead
sever
viral
pneumon
complic
bacteri
superinfect
lead
pneumonia
sepsi
season
influenza
also
occasion
result
neurolog
complic
even
nonpandem
year
death
annual
attribut
influenza
infect
unit
state
dushoff
et
al
much
rare
human
becom
infect
virus
spread
directli
wild
bird
domest
poultri
avian
influenza
rang
sever
mild
conjunct
rapidli
lethal
diseas
seen
person
infect
recent
emerg
southeast
asian
viru
howev
potenti
highli
virul
lethal
virus
spread
global
spanish
flu
pandem
result
tremend
effort
develop
vaccin
antivir
drug
block
spread
viru
treat
diseas
human
prevent
death
basic
virolog
clinic
syndrom
epidemiolog
approv
antivir
drug
influenza
viru
infect
present
tabl
effort
intensifi
recent
year
understand
pathogenesi
variou
form
influenza
viru
infect
develop
new
treatment
beigel
bray
develop
effect
antivir
therapi
wide
rang
diseas
essenti
laboratori
anim
model
replic
major
featur
ill
human
provid
select
sensit
reproduc
result
select
appropri
laboratori
anim
infect
import
drug
develop
process
anim
pig
ferret
natur
suscept
infect
influenza
virus
speci
use
influenza
studi
latter
viru
requir
adapt
replic
anim
andor
caus
diseas
eg
human
season
influenza
virus
mice
rat
influenza
virus
infect
anim
viru
may
caus
nonleth
diseas
lethal
diseas
type
diseas
induc
manipul
investig
depend
varieti
factor
includ
viru
strain
amount
viru
inoculum
rout
inocul
time
allow
diseas
develop
anim
immun
statu
paper
review
anim
model
current
use
studi
influenza
pathogenesi
immun
respons
influenza
viru
infect
assess
vaccin
antivir
drug
efficaci
model
review
includ
model
benign
influenza
typic
sever
season
influenza
pneumonia
influenzaassoci
sepsi
model
use
virus
model
acut
respiratori
distress
syndrom
ard
induc
model
influenzaassoci
neurolog
diseas
model
viru
transmiss
studi
immunocompromis
model
model
host
resist
influenza
usual
acut
selflimit
respiratori
tract
infect
begin
sudden
onset
high
fever
follow
inflamm
upper
respiratori
tree
trachea
coryza
cough
headach
prostrat
malais
sign
symptom
persist
day
viru
replic
upper
lower
respiratori
tract
experiment
infect
healthi
volunt
influenza
viral
replic
peak
approxim
hour
inocul
nasopharynx
declin
thereaft
usual
littl
viru
shed
six
day
howev
viral
antigen
still
detect
cell
respiratori
tract
secret
infect
individu
enzym
immunoassay
sever
day
infecti
viru
longer
recov
wright
et
al
summari
current
anim
model
avail
studi
benign
season
influenza
present
tabl
mice
infect
influenza
virus
low
pathogen
mild
ill
occur
sign
symptom
seen
human
major
paramet
mild
moder
diseas
weight
loss
detect
viru
primarili
lung
sidwel
smee
model
polymerbound
sialylnacetyllactosamin
found
amelior
weight
loss
treat
anim
less
virul
strain
influenza
viru
caus
mild
influenzalik
symptom
ferret
rare
end
death
exampl
ferret
infect
lose
weight
mild
respiratori
diseas
occur
aichiinfect
anim
occasion
sneez
littl
serou
nose
exud
express
viru
infect
elicit
rapid
strong
upregul
virul
strain
induc
significantli
lower
level
first
two
day
infect
first
four
day
infect
detect
sampl
anim
inocul
wherea
express
associ
virul
virus
util
ferret
model
benign
infect
induc
illustr
result
follow
vaccin
studi
ferret
immun
virosomebas
intranas
influenza
vaccin
consist
hemagglutinin
influenza
asydney
influenza
challeng
strain
less
viral
shed
nasal
secret
vaccin
elicit
vaccinespecif
antibodi
respons
lambkin
et
al
addit
vaccin
regimen
protect
fever
weight
loss
infiltr
inflammatori
cell
true
rat
speci
evalu
determin
suitabl
model
influenza
diseas
ascertain
whether
genet
background
impact
suscept
infect
one
studi
brown
norway
bn
spraguedawley
sd
rat
challeng
ratadapt
viru
viru
adapt
rat
success
passag
thorough
infect
lung
homogen
sd
rat
sensit
infect
higher
lung
viru
titer
seen
bn
rat
alveolar
macrophag
lactat
dehydrogenas
activ
total
lung
protein
concentr
indic
pulmonari
edema
higher
bn
rat
neutrophil
number
interleukin
level
activ
greatest
bronchoalveolar
lavag
fluid
sd
rat
nevertheless
infect
lethal
patholog
abnorm
note
lung
although
studi
provid
insight
factor
import
protect
host
influenza
viru
infect
rat
model
probabl
character
well
enough
recommend
use
evalu
antiinfluenza
therapi
recent
alarcon
et
al
influenza
virus
frequent
adapt
effici
transmiss
among
pig
anim
occasion
use
model
test
vaccin
van
der
laan
et
al
sign
ill
includ
fever
loss
appetit
labor
breath
cough
howev
anim
rare
die
diseas
unless
viru
directli
inocul
trachea
case
exhibit
sign
pneumonia
pig
found
low
suscept
recent
emerg
strain
lipatov
et
al
date
main
use
pig
develop
vaccin
swine
influenza
review
van
der
laan
et
al
problem
may
preclud
use
pig
influenza
studi
includ
cage
complex
anim
husbandri
wast
manag
thu
recent
develop
model
ellegaard
minipig
appear
offer
altern
anim
shown
develop
fulmin
pneumonia
use
less
intrus
rout
intratrach
inocul
howev
case
common
pig
minipig
suscept
infect
strain
normal
pig
one
must
alway
cautiou
obtain
anim
previou
exposur
influenza
virus
sinc
minipig
host
swine
influenza
virus
hansen
et
al
nonhuman
primat
much
close
relat
human
small
anim
typic
use
studi
influenza
use
model
human
diseas
particular
rhesu
macaqu
use
studi
pathogenesi
evalu
therapeut
prophylact
strategi
see
baa
et
al
review
addit
suitabl
pigtail
macaqu
model
influenza
context
transcript
studi
evalu
baskin
et
al
recent
studi
examin
innat
immun
respons
affect
lung
tissu
viral
genet
materi
present
baa
et
al
author
use
histopatholog
analysi
lung
tissu
immunohistochemistri
viral
host
gene
express
microarray
analysi
proteom
gene
express
circul
blood
cell
quantit
realtim
rtpcr
studi
individu
anim
respons
end
experi
infect
mild
without
pneumonia
signific
lung
patholog
investig
abl
demonstr
signific
differ
gene
express
within
region
influenza
virusinduc
lesion
base
presenc
absenc
viral
mrna
correl
transcript
marker
earli
diseas
peripher
white
blood
cell
baa
et
al
use
virus
caus
benign
infect
macaqu
primarili
use
vaccin
studi
exampl
rimmelzwaan
et
al
demonstr
protect
immun
induc
immun
stimul
complex
iscom
base
vaccin
consist
membran
glycoprotein
protect
macaqu
challeng
infect
howev
vaccin
monkey
prior
infect
influenza
viru
singl
dose
iscom
vaccin
induc
longlast
protect
antibodi
immun
challeng
infect
homolog
viru
occasion
healthi
individu
much
often
young
elderli
immunocompromis
acut
season
influenza
develop
hemorrhag
bronchiti
viral
pneumonia
character
dyspnea
hemoptysi
pulmonari
edema
cyanosi
death
occur
within
hour
onset
symptom
summari
anim
model
avail
studi
infect
present
tabl
case
sever
influenza
pneumonia
human
histolog
chang
lung
includ
capillari
small
vessel
thrombos
necrot
bronchiti
bronchiol
interstiti
edema
inflammatori
infiltr
format
hyalin
membran
alveoli
alveolar
duct
vari
degre
acut
edema
alveoli
without
hemorrhag
diffus
alveolar
damag
later
stage
diseas
character
organ
diffus
alveolar
damag
fibrosi
epitheli
regener
squamou
metaplasia
concomit
bacteri
fungal
infect
present
may
pronounc
neutrophil
infiltr
alveolar
air
space
lesser
degre
alveolar
hemorrhag
edema
primari
influenza
pneumonia
mous
remain
primari
model
evalu
antivir
therapi
influenza
pneumonia
due
inexpens
anim
cage
gener
fidel
ill
mice
human
diseas
sidwel
smee
addit
mani
reagent
avail
studi
effect
viru
replic
treatment
mous
immun
system
laboratori
mous
experiment
infect
season
influenza
virus
influenza
b
virus
usual
requir
adapt
multipl
lung
passag
adapt
viru
infect
murin
lung
cell
probabl
result
amino
acid
chang
surfac
hemagglutinin
enabl
bind
cellsurfac
alpha
sialic
acid
molecul
ibricev
et
al
recent
advanc
influenza
model
find
reconstruct
pandem
influenza
viru
lethal
mice
jefferi
et
al
taubenberg
number
paramet
may
use
monitor
influenza
viru
infect
mice
includ
chang
bodi
weight
declin
arteri
oxygen
satur
increas
serum
glycoprotein
mean
time
death
lung
weight
viral
titer
patholog
score
sidwel
smee
diseas
manifest
often
depend
infect
challeng
dose
viru
season
influenza
viru
strain
well
viru
adapt
host
viru
replic
mice
without
caus
appar
ill
effect
therapi
monitor
use
paramet
lung
viral
titer
increas
lung
weight
increas
glycoprotein
increas
nonleth
infect
mice
sidwel
smee
histopatholog
featur
influenza
viral
pneumonia
list
also
seen
mice
sign
symptom
human
influenza
rare
observ
mice
show
outward
sign
fever
increas
rectal
temperatur
dyspnea
cyanosi
hemoptysi
easili
ever
detect
mice
infect
strain
viru
howev
human
reduc
blood
oxygen
satur
level
measur
lung
function
measur
mice
level
dramat
lower
pneumonia
progress
mice
approach
death
barnard
et
al
weight
loss
also
good
marker
diseas
sever
sidwel
smee
reader
refer
follow
recent
paper
show
util
season
influenza
mous
model
evalu
vaccin
review
van
der
laan
et
al
hagenaar
et
al
hai
et
al
antivir
drug
dimmock
et
al
gilbert
mcleay
read
et
al
smee
et
al
wang
et
al
influenzavirusinfect
ferret
develop
mani
typic
sign
infect
human
includ
nasal
discharg
anorexia
wateri
eye
otolog
symptom
fever
use
anim
model
influenzalik
pneumonia
sidwel
smee
govorkova
et
al
smee
et
al
svitek
et
al
viru
high
titer
recov
respiratori
tract
smith
sweet
potter
et
al
although
ferret
mimic
season
influenza
infect
human
appear
less
respons
infect
influenza
b
virus
pinto
et
al
limit
ferret
studi
lack
specif
reagent
studi
ferret
immun
system
compar
similar
resourc
mice
howev
issu
probabl
resolv
near
futur
develop
reagent
crossreact
monoclon
antibodi
mab
exampl
cell
mous
bronchoalveolar
lavag
pneumon
ferret
identifi
mab
human
rutigliano
et
al
cage
also
problem
anim
facil
requir
ferret
hous
rabbitstyl
cage
system
proper
cage
work
influenza
viru
final
stage
develop
yet
avail
use
access
specif
pathogenfre
influenza
viru
seroneg
ferret
also
issu
becom
increasingli
demand
ferret
studi
grow
final
although
ferret
rel
passiv
tempera
rel
mink
cousin
becom
fairli
aggress
expos
invas
procedur
result
studi
describ
number
studi
done
show
adequaci
ferret
model
test
vaccin
efficaci
review
van
der
laan
et
al
huber
park
effect
antivir
drug
therapi
oxford
et
al
malakhov
et
al
cotton
rat
sigmodon
hispidu
sever
advantag
mice
ferret
model
human
influenza
includ
avail
reagent
studi
immunolog
respons
compar
mice
strain
cotton
rat
appear
innat
adapt
immun
respons
seen
human
mx
genemedi
respons
virus
isol
human
adapt
cotton
rat
caus
diseas
eichelberg
disadvantag
cotton
rat
primarili
anim
avail
aggress
speci
regardless
gender
influenza
cotton
rat
model
nasal
pulmonari
infect
adult
inbr
cotton
rat
anim
infect
intranas
dose
recent
influenza
strain
increas
breath
rate
accompani
weight
loss
decreas
temperatur
viru
replic
peak
within
h
lung
peak
titer
proport
infect
dose
although
viru
clear
lung
day
replic
persist
nasal
tissu
day
pulmonari
patholog
includ
earli
bronchiolar
epitheli
cell
damag
follow
extens
alveolar
interstiti
pneumonia
detect
anim
three
week
cytokin
level
typic
inflammatori
respons
lung
infect
upregul
appear
coincid
increas
viru
replic
sinc
model
gain
wide
accept
due
limit
describ
pauciti
paper
use
cotton
rat
vaccin
efficaci
straight
et
al
antivir
efficaci
eichelberg
et
al
stertz
et
al
influenza
viru
infect
although
influenza
viru
caus
pneumonia
secondari
bacteri
pneumonia
begin
either
shortli
recoveri
primari
viru
infect
much
common
speshock
et
al
coinfect
bacteria
season
influenza
pandem
associ
approxim
influenzarel
death
gupta
et
al
recent
paper
conclud
influenza
viru
infect
conjunct
bacteri
infect
led
death
pandem
number
anim
model
develop
evalu
suscept
influenzainfect
individu
bacteri
superinfect
caus
neisseria
meningitidi
alonso
et
al
streptococcu
pneumonia
hayashi
et
al
peltola
et
al
rosseau
et
al
smith
et
al
tabl
thu
effort
undertaken
establish
anim
model
mimic
influenza
infect
complic
bacteri
infect
primarili
pneumonia
mcculler
english
recent
propos
mechan
wherebi
secondari
bacteri
infect
occur
found
interferongamma
produc
lung
mice
tcell
respons
influenza
viru
infect
inhibit
bacteri
clearanc
alveolar
macrophag
higher
level
interferongamma
greater
suppress
phagocytosi
lead
enhanc
suscept
secondari
pneumococc
infect
infecti
agent
often
complic
influenza
streptococcu
pneumonia
superinfect
model
pneumococc
pneumonia
influenza
viru
infect
establish
sixweek
old
mice
use
subleth
dose
microb
hayashi
et
al
pneumonia
inocul
intranas
day
exposur
influenza
viru
death
presenc
agent
began
day
post
bacteri
exposur
efficaci
sever
quinolon
bacteriainduc
pneumonia
model
evalu
gatifloxacin
use
success
treat
pneumococc
infect
anoth
model
secondari
pneumococc
pneumonia
influenza
viru
infect
patholog
immunolog
led
fatal
diseas
studi
specif
look
cytokin
profil
influenzainfect
mice
challeng
serotyp
pneumonia
develop
sever
necrot
pneumonia
character
markedli
elev
level
proand
antiinflammatori
molecul
lung
accompani
massiv
influx
neutrophil
death
associ
develop
pneumonia
lung
inflamm
bacteremia
thu
model
may
use
delin
factor
associ
pathogenesi
sever
mix
lung
infect
meningococc
superinfect
model
balbc
mice
inocul
intranas
subleth
dose
mouseadapt
influenza
follow
intranas
inocul
neisseria
meningitidi
serogroup
c
alonso
et
al
fatal
meningococc
pneumonia
bacteremia
observ
influenzainfect
mice
superinfect
bacteria
day
day
thu
investig
abl
model
human
meningococcemia
fatal
sepsi
also
abl
examin
role
variou
bacteri
virul
factor
lead
sepsi
bacteri
superinfect
model
also
establish
ferret
influenza
close
resembl
found
human
peltola
et
al
goal
studi
better
understand
variou
sequela
pneumonia
infect
includ
otiti
media
sinus
pneumonia
determin
frequenc
charact
secondari
pneumococc
infect
differ
depend
strain
influenza
viru
preced
bacteri
challeng
report
human
virus
studi
virus
influenza
b
viru
b
sevenweekold
ferret
inocul
intranas
viru
day
later
pneumonia
virus
increas
bacteri
colon
nasopharynx
howev
ferret
infect
subtyp
influenza
virus
develop
either
sinus
otiti
media
infect
viru
influenza
b
viru
data
support
observ
human
bacteri
complic
rate
higher
season
virus
predomin
bhat
et
al
anim
model
could
use
studi
mechan
underli
viralbacteri
diseas
synerg
secondari
infect
staphylococcu
aureu
also
evalu
cotton
rat
braun
et
al
although
aureu
superinfect
rel
rare
complic
influenza
case
fatal
rate
extrem
high
addit
three
influenza
pandem
centuri
includ
case
coinfect
aureu
healthier
younger
patient
braun
et
al
therefor
physiolog
patholog
chang
cotton
rat
infect
aureu
influenza
evalu
compar
infect
cotton
rat
agent
alon
peribronchiol
interstiti
pneumon
well
alveol
observ
although
patholog
score
began
declin
coinfect
day
pi
remain
significantli
higher
infect
cohort
true
even
cohort
coinfect
inactiv
aureu
influenza
viru
coinfect
result
higher
mortal
infect
either
agent
alon
associ
mark
hypothermia
lung
patholog
enhanc
proinflammatori
cytokin
express
lung
braun
et
al
addit
bacteremia
prolong
bacteri
lung
titer
higher
coinfect
cotton
rat
contrast
humanadapt
influenza
virus
caus
benign
season
influenza
major
patient
recent
emerg
southeast
asian
viru
caus
acut
viral
pneumonia
aggrav
ard
toxic
shock
multipl
organ
failur
previous
healthi
immunocompet
individu
peiri
et
al
beigel
et
al
markedli
enhanc
virul
human
appear
least
part
reflect
differ
viral
tropism
cell
lower
respiratori
tract
recent
target
cell
unknown
human
mammal
van
riel
et
al
recent
studi
viru
found
preferenti
bind
type
ii
pneumocyt
alveolar
macrophag
noncili
bronchiolar
cell
lower
respiratori
tract
cat
similar
clinic
scenario
human
matrosovich
et
al
well
variou
anim
model
resembl
human
diseas
may
thu
reflect
differ
distribut
infect
respiratori
tract
viru
infect
wide
rang
mammalian
speci
without
prior
adapt
number
anim
model
avail
studi
tabl
isol
viru
recov
human
patient
caus
lethal
diseas
balbc
mice
without
prior
adapt
evseenko
et
al
hatta
et
al
hatta
kawaoka
isoda
et
al
katz
et
al
although
infect
primarili
pulmonari
strong
evid
system
spread
solid
organ
includ
brain
katz
et
al
virus
caus
necrosi
respiratori
epithelium
nasal
caviti
trachea
bronchi
bronchiol
katz
et
al
hatta
kawaoka
accompani
inflamm
accumul
fibrin
neutrophil
patholog
lung
character
peribronchi
alveol
intraalveolar
serofibrin
exud
erythrocyt
neutrophil
increas
number
alveolar
macrophag
often
infect
result
bronchointerstiti
pneumonia
alveolar
edema
sever
case
may
becom
diffus
interstiti
pneumonia
affect
entir
lung
lobe
bodi
temperatur
usual
decreas
four
five
degre
anim
lose
least
bodi
succumb
effect
infect
anoth
studi
recent
isol
shown
promot
significantli
higher
level
proinflammatori
cytokin
whole
lung
primari
human
macrophag
probabl
result
earli
excess
infiltr
macrophag
neutrophil
lung
mice
perron
et
al
anoth
studi
suggest
addit
typic
proinflammatori
cytokin
tnfa
may
also
contribut
morbid
influenza
viru
infect
szretter
et
al
sever
infect
human
caus
highli
pathogen
avian
influenza
virus
numer
vaccin
antivir
efficaci
studi
recent
done
mice
see
follow
recent
refer
vaccin
studi
review
van
der
laan
et
al
chen
et
al
chen
et
al
hickman
et
al
de
vri
et
al
antivir
efficaci
studi
barnard
et
al
boltz
et
al
ilyushina
et
al
zheng
et
al
two
virus
isol
hong
kong
outbreak
found
readili
infect
ferret
zitzow
et
al
sinc
isol
highli
pathogen
bird
found
replic
ferret
lung
without
prior
host
adapt
infect
gener
character
sever
lethargi
fever
weight
loss
transient
lymphopenia
viru
replic
upper
lower
respiratori
tract
multipl
organ
includ
brain
importantli
ill
induc
agent
sever
induc
recent
isol
human
virus
lung
ferret
show
diffus
inflamm
interalveolar
septa
infiltr
mononuclear
cell
intraalveolar
edema
regardless
time
post
infect
contrast
scatter
infiltr
seen
influenza
virus
chang
observ
throughout
lung
main
et
al
viral
antigen
detect
alveolar
bronchial
cell
bronchiol
major
anim
day
post
viru
exposur
brain
tissu
show
mononuclear
cell
infiltr
mening
choroid
plexu
brain
parenchyma
viral
antigen
detect
neuron
area
effort
determin
viru
virul
ferret
season
influenza
isol
cameron
et
al
analyz
express
host
innat
immun
respons
gene
cours
lethal
infect
author
found
mani
interferon
respons
gene
includ
significantli
upregul
ferret
infect
viru
comparison
isol
chemoattract
activ
lymphocyt
natur
killer
cell
also
upregul
much
greater
extent
infect
viru
receptor
thought
play
role
tempor
develop
innat
adapt
immun
concert
type
ii
interferon
nevil
et
al
support
hypothesi
cameron
et
al
found
treatment
ferret
antagonist
markedli
reduc
sever
symptom
delay
death
compar
untreat
anim
vaccin
review
subbarao
luke
chen
al
lalor
et
al
mahmood
et
al
number
antivir
compound
malakhov
et
al
govorkova
et
al
boltz
et
al
yun
et
al
test
ferret
infect
virus
often
verifi
find
mice
malakhov
et
al
govorkova
et
al
boltz
et
al
yun
et
al
rimmelzwaan
et
al
assess
virul
viru
cat
infect
intratrach
inocul
feed
virusinfect
chick
within
two
day
anim
develop
fever
conjunct
lethargi
labor
breath
viru
detect
throat
nasal
rectum
regardless
origin
site
infect
viru
spread
system
detect
respiratori
digest
tract
liver
kidney
heart
brain
lymph
node
cellular
damag
infect
tissu
correl
detect
viral
protein
histopatholog
examin
lung
reveal
multipl
coalesc
foci
inflamm
necrosi
bronchiol
alveolar
bronchiolar
lumina
infiltr
alveolar
macrophag
neutrophil
erythrocyt
mix
fibrin
edema
fluid
cellular
debri
importantli
alveoli
cover
hyalin
membran
also
seen
human
lung
upon
autopsi
hyalin
membran
format
observ
mice
anim
model
epithelium
bronchiolar
alveolar
wall
moder
thicken
also
evid
necrosi
hyperplasia
also
edema
moder
accumul
mononuclear
cell
around
pulmonari
arteri
branch
although
work
defin
cat
influenza
model
evalu
pathogenesi
infect
studi
publish
describ
suitabl
cat
vaccin
karaca
et
al
vahlenkamp
et
al
antivir
efficaci
studi
dog
also
infect
avian
influenza
viru
anim
often
close
contact
wild
domest
bird
human
rais
possibl
viru
could
adapt
dog
transmit
human
retain
virul
date
found
dog
suscept
experiment
infect
capabl
transmit
viru
mammal
gies
et
al
diseas
dog
character
develop
conjunct
fever
within
day
viru
exposur
resolv
advers
event
day
dog
may
use
sentinel
human
diseas
model
human
influenza
diseas
cleaveland
et
al
cynomolgu
macaqu
macaca
fasciculari
model
viru
infect
pneumonia
ard
develop
rimmelzwaan
et
al
princip
chang
lung
necrot
bronchial
interstiti
pneumonia
similar
describ
primari
human
influenza
pneumonia
contrast
human
case
detect
influenza
viru
antigen
limit
pulmonari
tissu
tonsil
model
use
evalu
efficaci
intraven
zanamivir
longer
halflif
oseltamivir
stittelaar
et
al
drug
level
epitheli
line
fluid
lung
equival
plasma
treat
macaqu
lower
gross
patholog
score
less
lung
patholog
untreat
anim
howev
consider
variabl
viral
lung
titer
gross
patholog
within
group
macaqu
scatter
foci
lung
infect
anim
anim
make
difficult
establish
statist
signific
differ
author
point
variabl
probabl
reflect
happen
within
human
popul
vaccin
studi
macaqu
also
done
de
vri
et
al
kreijtz
et
al
ruat
et
al
among
other
ard
character
local
hyperinflammatori
respons
infecti
agent
lung
result
damag
alveoluscapillari
interfac
hammerbeck
et
al
virusinfect
human
initi
present
clinic
sign
influenzalik
ill
develop
progress
pneumonia
may
eventu
die
ard
grose
chokephaibulkit
thu
research
done
develop
model
ard
virusinfect
mice
one
ard
model
use
balbc
mice
inocul
intranas
influenza
viru
anim
develop
typic
ard
highli
edemat
lung
dramat
increas
lung
weight
progress
hypoxemia
mortal
day
xu
et
al
histolog
examin
reveal
inflammatori
cell
infiltr
alveoli
signific
increas
neutrophil
interstiti
edema
hemorrhag
level
tnfa
bronchiolar
lavag
fluid
significantli
increas
model
thu
display
signific
sign
symptom
associ
ard
human
summari
current
anim
model
avail
studi
ard
influenza
shown
tabl
number
studi
describ
neurolog
sequala
influenza
viru
infect
anim
model
complic
studi
treatment
test
would
import
mizuguchi
et
al
steining
et
al
summari
current
anim
model
avail
studi
influenza
virusassoci
neurotrop
diseas
present
tabl
mori
et
al
use
highli
neurovirul
recombin
strain
influenza
viru
test
amantadin
therapi
mice
stereotax
microinject
viru
olfactori
bulb
anim
result
outward
spread
neuron
broad
area
brain
parenchyma
lead
apoptot
neurogener
fatal
edema
begin
day
eight
howev
amantadin
treatment
begin
late
seven
day
viru
inject
protect
anim
disadvantag
clinic
relev
model
research
stereotax
microinject
equip
could
use
second
studi
mice
use
neurovirul
strain
influenza
viru
administ
intranas
result
infect
olfactori
neuron
anterograd
axon
transport
olfactori
bulb
aronsson
et
al
use
immunodefect
mutant
mice
examin
immun
system
control
spread
persist
viru
author
show
absenc
b
cell
allow
infect
spread
fulli
brain
simplifi
neurovirul
model
park
et
al
demonstr
simpl
intranas
instil
influenza
viru
isol
patient
hong
kong
outbreak
could
result
infect
murin
central
nervou
system
initi
replic
respiratori
mucosa
viru
appar
travel
affer
fiber
olfactori
vagal
trigemin
sympathet
nerv
detect
immunohistochem
situ
hybrid
studi
demonstr
feasibl
use
intranas
instal
virus
isol
directli
patient
establish
encephalitislik
infect
ideal
way
quickli
evalu
antivir
inhibitor
yun
et
al
inject
peramivir
intramuscularli
ferret
infect
intranas
highli
neurovirul
influenza
viru
abl
show
peramavir
deliv
manner
amelior
virusinduc
diseas
reduc
infecti
viru
titer
lung
brain
promot
surviv
ferret
potenti
influenza
virus
develop
resist
amantadin
rimantadin
well
establish
clinic
studi
monto
arden
hayden
hay
englund
et
al
mice
sidwel
smee
contrast
virus
acquir
resist
zanamivir
oseltamivir
gener
display
signific
reduct
infect
mice
compar
parent
virus
gubareva
et
al
herloch
et
al
yen
et
al
reduct
virul
evalu
sever
mean
one
studi
mice
infect
parallel
equal
quantiti
parent
mutant
virus
lung
remov
earli
infect
gubareva
et
al
viru
titer
determin
titer
challeng
virus
need
induc
infect
compar
amount
viru
produc
lung
equival
concentr
virus
quantifi
tai
et
al
altern
use
mouseadapt
influenza
viru
rel
virul
mutant
viru
assess
use
paramet
increas
lung
weight
lung
pathogenesi
score
lung
histopatholog
decreas
sao
level
lung
sidwel
et
al
ferret
use
extens
studi
infect
virul
influenza
viru
mutant
resist
neuraminidas
inhibitor
blick
et
al
gubareva
et
al
barnett
et
al
blick
et
al
found
zanamivirresist
influenza
viru
na
ha
mutat
resist
zanamivir
ferret
even
though
small
decreas
sensit
drug
shown
mice
indic
potenti
differ
two
model
studi
drugresist
virus
summari
current
anim
model
avail
studi
drugresist
influenza
viru
infect
present
tabl
influenza
particularli
seriou
individu
congenit
acquir
immunodefici
age
cancer
treatment
organ
transplant
human
immunodefici
viru
infect
lee
barton
therefor
import
model
evalu
effect
chemotherapi
influenza
viru
infect
immunosuppress
anim
tabl
cyclophosphamid
treatment
use
immunosuppress
mice
assess
efficaci
neuraminidas
inhibitor
peramivir
immunocompromis
host
sidwel
et
al
cyclophosphamid
inject
intraperiton
dose
mgkg
everi
four
day
vari
length
time
peramivir
capabl
significantli
amelior
influenza
viru
infect
mice
immunosuppress
shortterm
prolong
cyclophosphamid
therapi
sever
combin
immunodefici
scid
mice
also
provid
model
evalu
antiinfluenza
treatment
immunocompromis
host
recent
studi
scid
mice
infect
influenza
viru
treat
either
oral
oseltamivir
experiment
compound
show
reduc
viral
replic
limit
weight
loss
prolong
surviv
long
treatment
persist
sidwel
et
al
howev
treatment
discontinu
anim
detect
progress
viral
replic
subsequ
clinic
declin
importantli
drugresist
viru
detect
chronic
infect
drugtreat
mice
placebotr
anim
die
rapidli
infect
effect
immun
clearanc
influenza
viru
requir
immun
system
intact
function
normal
host
resist
model
therefor
use
evalu
effect
antivir
treatment
viru
clearanc
indic
immunocompet
anim
treatment
test
immunotox
particular
agent
mechanist
studi
detect
immunotox
includ
measur
innat
humor
cell
mediat
immun
respons
paramet
cytokin
interferon
product
macrophag
function
natur
killer
cell
function
cytotox
lymphocyt
activ
well
influenzaspecif
antibodi
drug
treatment
exampl
compound
synthet
human
agonist
evalu
antivir
efficaci
immunotox
rat
hr
model
parallel
human
influenza
infect
respect
time
cours
develop
respiratori
tract
lesion
hammerbeck
et
al
burleson
burleson
intranas
administr
significantli
inhibit
influenza
viral
replic
nasal
caviti
anim
pretreat
therapeut
treat
compound
inhibit
correl
close
induct
type
interferon
lesser
extent
cytokin
rat
peripher
blood
mononuclear
cell
seem
neg
effect
immun
respons
infect
pose
signific
threat
human
novel
influenza
viru
must
abl
replic
human
respiratori
tract
transmit
effici
person
person
clearli
demonstr
recent
emerg
avian
influenza
viru
caus
rapidli
overwhelm
pneumonia
rare
spread
patient
close
contact
anim
model
develop
evalu
pandem
potenti
influenza
virus
especi
agent
one
recent
studi
yen
et
al
hous
ferret
infect
neuraminidas
inhibitor
resist
recombin
influenza
viru
togeth
uninfect
ferret
monitor
ill
detect
viru
shed
lung
viral
titer
death
observ
limit
transmiss
infect
health
contact
correl
low
amount
viru
respiratori
secret
author
conclud
molecular
determin
addit
viru
receptor
bind
affin
respons
influenza
viru
transmiss
among
mammalian
speci
yen
et
al
guinea
pig
also
evalu
transmiss
model
mammalian
host
influenza
viru
guinea
pig
found
highli
suscept
infect
unadapt
viru
viru
replic
high
titer
upper
respiratori
tract
lowen
et
al
although
anim
sneez
cough
viru
shed
nasal
wash
experi
perform
ambient
temperatur
low
humid
viru
transmit
infect
noninfect
guinea
pig
hous
either
cage
adjac
cage
cage
place
cm
away
transmiss
appear
droplet
spread
effici
lower
ambient
temperatur
humid
shown
review
sever
speci
laboratori
anim
prove
use
research
influenza
mice
particularli
balbc
strain
current
intens
employ
studi
pathogenesi
demonstr
efficaci
antivir
drug
preliminari
efficaci
studi
vaccin
studi
antivir
agent
shown
infect
mice
predict
efficaci
human
exampl
current
approv
drug
treat
influenza
viru
infect
first
shown
efficaci
mice
although
mice
readili
suscept
newli
isol
human
season
influenza
virus
requir
viru
adapt
mani
highli
pathogen
avian
influenza
strain
requir
adapt
readili
infect
mice
caus
lethal
diseas
mice
also
exhibit
clinic
symptom
detect
human
nasal
exud
fever
sneez
cough
howev
mani
clinic
sign
seem
marker
diseas
sever
measur
mice
studi
influenza
diseas
satur
oxygen
level
viru
lung
titer
cytokin
level
serum
acut
phase
protein
addit
use
mous
model
enabl
investig
rapidli
evalu
efficaci
antivir
agent
vaccin
rel
lesser
cost
anim
model
ferret
wide
use
supplement
valid
studi
mice
especi
viru
studi
order
compli
new
fda
two
anim
rule
tremend
advantag
ferret
anim
display
mani
clinic
symptom
human
influenza
model
also
similar
complex
human
howev
mous
model
mani
host
factor
found
associ
human
miss
yet
discov
ferret
cost
ferret
space
need
hous
tempera
anim
handl
experiment
avail
anim
without
prior
exposur
influenza
remain
concern
anim
speci
could
use
model
suffici
studi
suitabl
routin
use
studi
influenza
diseas
influenza
pathogenesi
addit
immun
reagent
speci
remain
yet
develop
avail
speci
limit
cost
hous
handl
larger
speci
great
despit
evid
great
influenza
pandem
brought
death
million
peopl
influenza
often
view
nuisanc
diseas
adequ
countermeasur
alreadi
avail
howev
recent
emerg
highli
virul
avian
influenza
viru
southeast
asia
serv
wakeup
call
remind
medic
commun
novel
influenza
virus
unexpectedli
enter
human
popul
even
current
circul
season
strain
respons
hundr
thousand
death
worldwid
year
influenza
virus
far
benign
respiratori
pathogen
major
public
health
problem
call
seriou
sustain
research
respons
essenti
part
process
develop
laboratori
anim
model
influenza
viru
infect
studi
pathogenesi
evalu
new
drug
vaccin
describ
paper
number
anim
model
develop
mani
gap
remain
mani
current
model
remain
incomplet
character
none
employ
full
potenti
new
better
model
need
provid
accur
answer
critic
question
pathogenesi
therapi
hope
paper
contribut
better
use
laboratori
anim
model
combat
continu
threat
influenza
influenza
viru
infect
basic
classif
structur
influenza
virus
spheric
pleomorph
singlestrand
negativesens
rna
virus
belong
famili
orthomyxovirida
influenza
b
virus
contain
eight
separ
ribonucleoprotein
rnp
segment
influenza
c
viru
contain
seven
encod
protein
intern
antigen
np
protein
typespecif
antigen
use
determin
particular
viru
b
c
extern
hemagglutinin
ha
neuraminidas
na
subtypeand
strainspecif
antigen
influenza
viru
bind
receptor
surfac
host
cell
via
ha
protein
intern
endosom
phdepend
fusion
uncoat
releas
viral
rnp
cytoplasm
transport
nucleu
replic
viral
messeng
rna
export
nucleu
protein
synthesi
result
protein
transport
back
nucleu
assist
replic
rnp
assembl
new
rnp
assembl
viru
protein
matrix
form
virion
bud
plasma
membran
influenza
virus
caus
chronic
asymptomat
infect
gastrointestin
tract
wild
bird
also
abl
infect
caus
diseas
varieti
mammal
avian
virus
caus
rang
ill
human
rang
conjunct
fulmin
ill
caus
recent
emerg
viru
rare
occas
influenza
viru
introduc
human
popul
spread
rapidli
caus
global
pandem
occur
either
avian
viru
novel
ha
protein
adapt
humantohuman
transmiss
avian
viru
undergo
genom
reassort
coinfect
influenza
virusinfect
mammal
pig
pandem
viru
circul
undergo
progress
antigen
drift
ha
na
protein
permit
reinfect
popul
regular
outbreak
season
influenza
clinic
syndrom
symptom
season
influenza
typic
includ
high
fever
chill
headach
sore
throat
dri
cough
myalgia
anorexia
malais
complic
includ
primari
viral
pneumonia
secondari
bacteri
pneumonia
combin
bacteri
viral
pneumonia
sever
infect
caus
recent
emerg
avian
influenza
viru
character
rapid
develop
diffus
interstiti
pneumonia
viremia
shock
lead
death
inactiv
vaccin
fluvirin
obtain
infect
chicken
embryo
commonli
use
attenu
vaccin
includ
approv
therapeut
approv
therapeut
season
influenza
viru
infect
includ
neuraminidas
inhibitor
oseltamivir
phosphat
zanamivir
ion
channel
blocker
amantadin
rimantadin
summari
current
anim
model
avail
studi
human
diseas
caus
highli
pathogen
avian
virus
